Debt-to-equity in % of INNOVATIVE MEDTECH, INC. from Q1 2012 to Q1 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Innovative Medtech, Inc. quarterly Debt-to-equity history and change rate from Q1 2012 to Q1 2025.
  • Innovative Medtech, Inc. Debt-to-equity for the quarter ending 31 Mar 2025 was -120 %, a 70.8% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

INNOVATIVE MEDTECH, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q1 2025 -120 +292 +70.8% 31 Mar 2025
Q4 2024 -146 +162 +52.6% 31 Dec 2024
Q3 2024 -181 +93.8 +34.2% 30 Sep 2024
Q2 2024 -243 +17 +6.53% 30 Jun 2024
Q1 2024 -412 -150 -57.5% 31 Mar 2024
Q4 2023 -308 +41.3 +11.8% 31 Dec 2023
Q3 2023 -275 +240 +46.7% 30 Sep 2023
Q2 2023 -260 +637 +71% 30 Jun 2023
Q1 2023 -261 +1.65K +86.3% 31 Mar 2023
Q4 2022 -349 31 Dec 2022
Q3 2022 -515 30 Sep 2022
Q2 2022 -897 30 Jun 2022
Q1 2022 -1.91K 31 Mar 2022
Q3 2014 -100 -0.01 -0.01% 31 Oct 2014
Q2 2014 -100 0 0% 31 Jul 2014
Q1 2014 -100 30 Apr 2014
Q4 2013 -100 31 Jan 2014
Q3 2013 -100 31 Oct 2013
Q2 2013 -100 31 Jul 2013
Q1 2012 -105 30 Apr 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.